NXTC

NextCure, Inc. - Common Stock (NXTC)

About NextCure, Inc. - Common Stock (NXTC)

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Details

Daily high

$11.48

Daily low

$10.88

Price at open

$11.19

52 Week High

$15.74

52 Week Low

$2.69

Market cap

59.7M

Dividend yield

0.00%

Volume

28,473

Avg. volume

57,359

P/E ratio

-.47

NextCure, Inc. - Common Stock News